CIK 0001676725 · Large accelerated filer
IDEAYA Biosciences, Inc.
Sign in to watch- Ticker
- IDYA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474268251
- Phone
- 650-443-6209
- Business address
- 5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $985,397
- in 1 filing, $985K under 10b5-1 plans
Net −$985,397. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-06 | Dillon Michael P. SVP, Chief Scientific Officer | Option exercise · Stock Option (right to buy) | −1,500 | 44,500 | ||
| 2021-07-06 | Throne Jason SVP, General Counsel | Option exercise | +7,610 | $7.01 | $53K | 7,610 |
| 2021-07-06 | Throne Jason SVP, General Counsel | Option exercise | +2,390 | $13.34 | $32K | 10,000 |
| 2021-07-06 | Throne Jason SVP, General Counsel | Sale | −6,468 | $22.16 | $143K | 3,532 |
| 2021-07-06 | Throne Jason SVP, General Counsel | Sale | −1,142 | $22.68 | $26K | 2,390 |
| 2021-07-06 | Throne Jason SVP, General Counsel | Sale | −2,031 | $22.16 | $45K | 359 |
| 2021-07-06 | Throne Jason SVP, General Counsel | Sale | −359 | $22.68 | $8K | 0 |
| 2021-07-06 | Throne Jason SVP, General Counsel | Option exercise · Stock Option (right to buy) | −7,610 | 67,390 | ||
| 2021-07-06 | Throne Jason SVP, General Counsel | Option exercise · Stock Option (Right to Buy) | −2,390 | 72,610 | ||
| 2021-06-17 | Dillon Michael P. SVP, Chief Scientific Officer | Option exercise | +3,893 | $6.92 | $27K | 102,682 |
| 2021-06-17 | Dillon Michael P. SVP, Chief Scientific Officer | Sale | −3,893 | $22.49 | $88K | 98,789 |
| 2021-06-17 | Dillon Michael P. SVP, Chief Scientific Officer | Option exercise · Stock Option (right to buy) | −3,893 | 46,000 | ||
| 2021-06-16 | Dillon Michael P. SVP, Chief Scientific Officer | Option exercise | +1,107 | $6.92 | $8K | 99,896 |
| 2021-06-16 | Dillon Michael P. SVP, Chief Scientific Officer | Sale | −1,107 | $22.47 | $25K | 98,789 |
| 2021-06-16 | Dillon Michael P. SVP, Chief Scientific Officer | Option exercise · Stock Option (right to buy) | −1,107 | 49,893 | ||
| 2021-06-10 | SHANNON TIMOTHY M Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2021-06-10 | YARNO WENDY L Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2021-06-10 | Stein Jeffrey Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2021-06-10 | ROSEN TERRY J Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2021-06-10 | Morrison Scott W Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 |
Page 11 of 19 · 370 trades